E-LIB Suche - Ergebnisse für: Bourcier, T

1

Prise en charge de la toxoplasmose oculaire en France : res..:

SCHAEFFER, M ; BALLONZOLI, L ; GAUCHER, D...
0181-5512. , 2022

2

Efficacy and Safety of 0.1% Cyclosporine versus 2% Cyclospo..:

Bourcier T ; Dory A ; Dormegny L...
https://www.dovepress.com/efficacy-and-safety-of-01-cyclosporine-versus-2-cyclosporine-in-the-tr-peer-reviewed-fulltext-article-OPTH. , 2022

Link: https://doaj.org/article..

3

Aciclovir-resistant HSV1 keratitis: a clinical and virologi..:

ROUSSEAU, A ; BURREL, S ; GUEUDRY, J...
1755-375X. , 2018

Link: https://oskar-bordeaux.f..

4

Effects of air pollution and climatic conditions on the fre..:

Bourcier, T ; Viboud, Cecile ; Cohen, J-C...
info:eu-repo/semantics/altIdentifier/doi/10.1136/bjo.87.7.809. , 2003

Link: https://archive-ouverte...

5

Efficacy of N‐acetyl aspartyl glutamic acid versus fluorome..:

De Blay De Gaix, F. (Frederic) ; Gherasim, A. (Alina) ; Domis, N. (Nathalie).. , 2022

Link: https://onlinelibrary.wi..

6

Driving Skills Tested on Simulator After Strabismus Surgery..:

Derhy, D. (Dan) ; Lithfous, S. (Ségolène) ; Speeg, C. (Claude)... , 2020

Link: https://tvst.arvojournal..

7

Time to treatment with bridging intravenous alteplase befor..:

Meinel, T. R ; Kaesmacher, J ; Buetikofer, L...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jnis-2022-019207. , 2023

Link: https://inserm.hal.scien..

8

Time to treatment with bridging intravenous alteplase befor..:

Meinel, T. R ; Kaesmacher, J ; Buetikofer, L...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jnis-2022-019207. , 2023

Link: https://inserm.hal.scien..

9

Time to treatment with bridging intravenous alteplase befor..:

Meinel, T. R ; Kaesmacher, J ; Buetikofer, L...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jnis-2022-019207. , 2023

Link: https://inserm.hal.scien..

10

Time to treatment with bridging intravenous alteplase befor..:

Meinel, Thomas R ; Kaesmacher, Johannes ; Buetikofer, Lukas...
https://boris.unibe.ch/171657/. , 2023

Link: https://boris.unibe.ch/1..

11

Time to treatment with bridging intravenous alteplase befor..:

Meinel, T. R ; Kaesmacher, J ; Buetikofer, L...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jnis-2022-019207. , 2023

Link: https://inserm.hal.scien..

12

Time to treatment with bridging intravenous alteplase befor..:

Meinel, T. R ; Kaesmacher, J ; Buetikofer, L...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jnis-2022-019207. , 2023

Link: https://inserm.hal.scien..

13

Time to treatment with bridging intravenous alteplase befor..:

Meinel, Thomas R ; Kaesmacher, Johannes ; Darcourt, Jean...
info:eu-repo/semantics/altIdentifier/pmid/pmid:35902234. , 2023

Link: https://publications.rwt..

14

Time to treatment with bridging intravenous alteplase befor..:

Meinel, T. R ; Kaesmacher, J ; Buetikofer, L...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jnis-2022-019207. , 2023

Link: https://inserm.hal.scien..

15

Time to treatment with bridging intravenous alteplase befor..:

Meinel, T. R ; Kaesmacher, J ; Buetikofer, L...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jnis-2022-019207. , 2023

Link: https://inserm.hal.scien..